Screener/Healthcare/Biotechnology

AUPH

Aurinia Pharmaceuticals Inc.NASDAQ
$14.22-0.34 (-2.34%)
Small CapUnder $20HealthcareFastest GrowingHigh BetaHigh ROELow P/EUndervalued
$6.83
$16.54
$13.85
$14.56
EPS (TTM)$2.08
P/E Ratio6.84
Dividend Yield—
Market Cap$1.90B
Volume1.25M
Prev Close$14.56
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$77.1M$210.8M$1.5388.6%273.4%
Q3 '25$73.5M$31.6M$0.2388.9%42.9%
Q2 '25$70.0M$21.5M$0.1689.8%30.7%
Q1 '25$62.5M$23.3M$0.1686.3%37.4%
Q3 '24$67.8M$14.3M$0.1091.1%21.2%
Q2 '24$57.2M$722K$0.0184.4%1.3%
Q1 '24$50.3M-$10.7M$-0.0784.6%-21.4%
Q4 '23$45.1M-$26.9M$-0.1988.0%-59.6%
Get Your Daily Market Recap